Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial.
Kantrowitz JT, Woods SW, Petkova E, Cornblatt B, Corcoran CM, Chen H, Silipo G, Javitt DC. Kantrowitz JT, et al. Lancet Psychiatry. 2015 May;2(5):403-412. doi: 10.1016/S2215-0366(15)00098-X. Epub 2015 Apr 28. Lancet Psychiatry. 2015. PMID: 26360284 Clinical Trial.
Tardive Dyskinesia Suppressed With Ginkgo Biloba.
Petridis PD, Jaffe AB, Kantrowitz JT, Grinband J. Petridis PD, et al. Among authors: kantrowitz jt. J Clin Psychopharmacol. 2023 Nov-Dec 01;43(6):549-551. doi: 10.1097/JCP.0000000000001764. Epub 2023 Oct 17. J Clin Psychopharmacol. 2023. PMID: 37930215 No abstract available.
High dose D-serine in the treatment of schizophrenia.
Kantrowitz JT, Malhotra AK, Cornblatt B, Silipo G, Balla A, Suckow RF, D'Souza C, Saksa J, Woods SW, Javitt DC. Kantrowitz JT, et al. Schizophr Res. 2010 Aug;121(1-3):125-30. doi: 10.1016/j.schres.2010.05.012. Epub 2010 Jun 11. Schizophr Res. 2010. PMID: 20541910 Free PMC article. Clinical Trial.
86 results